|
1
|
Involvement of autophagy in trypsinogen activation within the pancreatic acinar cells.
|
J Cell Biol
|
2008
|
1.85
|
|
2
|
Applicability of disseminated intravascular coagulation parameters in the assessment of the severity of acute pancreatitis.
|
Pancreas
|
2006
|
1.56
|
|
3
|
Serine protease inhibitor Kazal type 1 promotes proliferation of pancreatic cancer cells through the epidermal growth factor receptor.
|
Mol Cancer Res
|
2009
|
1.12
|
|
4
|
Enhanced trypsin activity in pancreatic acinar cells deficient for serine protease inhibitor kazal type 3.
|
Pancreas
|
2006
|
1.03
|
|
5
|
c-FLIP maintains tissue homeostasis by preventing apoptosis and programmed necrosis.
|
Sci Signal
|
2012
|
1.01
|
|
6
|
The role of trypsin, trypsin inhibitor, and trypsin receptor in the onset and aggravation of pancreatitis.
|
J Gastroenterol
|
2006
|
0.97
|
|
7
|
C/EBP homologous protein is crucial for the acceleration of experimental pancreatitis.
|
Biochem Biophys Res Commun
|
2007
|
0.91
|
|
8
|
Proinflammatory role of trypsin and protease-activated receptor-2 in a rat model of acute pancreatitis.
|
Pancreas
|
2005
|
0.89
|
|
9
|
Further evidence for endothelin as an important mediator of pancreatic and intestinal ischemia in severe acute pancreatitis.
|
Pancreas
|
2003
|
0.89
|
|
10
|
Genetic background of pancreatitis.
|
Postgrad Med J
|
2006
|
0.88
|
|
11
|
Expression pattern of serine protease inhibitor kazal type 3 (Spink3) during mouse embryonic development.
|
Histochem Cell Biol
|
2008
|
0.88
|
|
12
|
From acute to chronic pancreatitis: the role of mutations in the pancreatic secretory trypsin inhibitor gene.
|
JOP
|
2003
|
0.87
|
|
13
|
Relationship of strain-dependent susceptibility to experimentally induced acute pancreatitis with regulation of Prss1 and Spink3 expression.
|
Lab Invest
|
2010
|
0.87
|
|
14
|
Pancreatic cancer in the remnant pancreas following primary pancreatic resection.
|
Surg Today
|
2013
|
0.87
|
|
15
|
Screening methods to identify TALEN-mediated knockout mice.
|
Exp Anim
|
2014
|
0.86
|
|
16
|
Heterogeneity of KRAS Mutations in Pancreatic Ductal Adenocarcinoma.
|
Pancreas
|
2016
|
0.84
|
|
17
|
Staging laparoscopy leads to rapid induction of chemotherapy for unresectable pancreatobiliary cancers.
|
Asian J Endosc Surg
|
2015
|
0.84
|
|
18
|
Pancreaticodigestive anastomosis and the postoperative management strategies to prevent postoperative pancreatic fistula formation after pancreaticoduodenectomy.
|
Surg Today
|
2013
|
0.82
|
|
19
|
Transgenic expression of pancreatic secretory trypsin inhibitor-1 rescues SPINK3-deficient mice and restores a normal pancreatic phenotype.
|
Am J Physiol Gastrointest Liver Physiol
|
2010
|
0.81
|
|
20
|
Chronic pancreatitis in mice by treatment with choline-deficient ethionine-supplemented diet.
|
Exp Anim
|
2010
|
0.81
|
|
21
|
Application of oocyte cryopreservation technology in TALEN-mediated mouse genome editing.
|
Exp Anim
|
2014
|
0.81
|
|
22
|
Non-occlusive mesenteric ischemia and its associated intestinal gangrene in acute pancreatitis.
|
Pancreatology
|
2003
|
0.79
|
|
23
|
Significance of endothelial molecular markers in the evaluation of the severity of acute pancreatitis.
|
Surg Today
|
2009
|
0.76
|
|
24
|
Dynamic aspects of granulocyte activation in rat severe acute pancreatitis.
|
Pancreas
|
2003
|
0.76
|
|
25
|
Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.
|
J Hepatobiliary Pancreat Sci
|
2013
|
0.76
|
|
26
|
Generation and analysis of serine protease inhibitor kazal type 3-cre driver mice.
|
Exp Anim
|
2014
|
0.75
|
|
27
|
Effect of low-molecular weight trypsin inhibitor, nafamostat mesilate, on trypsin activity using the pancreatic acinar cells.
|
Pancreas
|
2009
|
0.75
|
|
28
|
Clinical features and management of pancreatic solid pseudopapillary tumor.
|
Am Surg
|
2014
|
0.75
|